Dr. Abou-Alfa Discusses Treatment Options in Liver Cancer OncLive Ghassan K. Abou-Alfa, MD, medical oncologist, Memorial Sloan Kettering Cancer Center, discusses treatment options in liver cancer. 2017 brought about the FDA approval of regorafenib (Stivarga) as a second-line treatment for patients with hepatocellular ...
Blood test promising to detect early cancers; Madison's Exact Sciences leader in field - Madison.com
What our clients and candidates are saying about us: You may not remember me, but...you were a big help in jump-starting my new career search. I really appreciate your help, and I look forward to hearing from you! - Kris
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.